Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 20;40:294. doi: 10.1186/s13046-021-02096-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 4 — LINC00022 promotes cell-cycle progression in ESCC cells. (A) Cell cycle phase distribution of KYSE150 and TE1 following siRNA-mediated knockdown of LINC00022 was detected by PI-staining flow cytometry (left panel). Ablation of LINC00022 led to a significant increase in the proportion of cells in G0/G1 phase, a slight decrease in the proportion of cells in S phase but with no significant difference, and an obvious decrease in the proportion of cells in G2/M phase (right panel), *p < 0.05; **p < 0.01; ns means no significance. (B) Cell-cycle change of KYSE70 cells after LINC00022 over-expression was evaluated by PI-labeling flow cytometry (upper panel). Up-regulation of LINC00022 resulted in a significant reduction in the proportion of cells in G0/G1 phase, a slight increase in the proportion of cells in S phase but with no significant difference, and a dramatic elevation in the proportion of cells in G2/M phase (nether panel), *p < 0.05; **p < 0.01; ns means no significance. (C-E) Western blot was used to detect the changes of cell cycle regulator protein levels in KYSE150 (C) and TE1 (D) cells following LINC00022 knockdown, and in KYSE70 (E) cells following LINC00022 over-expression. The positive cell-cycle regulators include CDK2, Cyclin E1, CDK4 and Cyclin D1, while the negative regulators include p16, p21 and p53. The numbers below each band represent the relative protein levels change